About Dermik

Dermik's mission is to foster healthy skin and nails, and in turn, a healthy outlook for life.

Dermik Laboratories conducts the North American business of sanofi-aventis Dermatology, the global dermatology unit of sanofi-aventis. Dermik has nearly 60 years of experience in the development, marketing, and distribution of innovative prescription pharmaceutical products. Dermik has created a new division, Dermik Aesthetics, that will focus on marketing innovative, enduring, and reliable treatments to improve appearance and well-being. Dermik's mission is to foster healthy-looking skin and in turn, a healthy outlook for life.

About sanofi-aventis

The sanofi-aventis Group is the world's third largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, diabetes, central nervous system, internal medicine, and vaccines. The sanofi-aventis Group conducts business in the U.S. through its subsidiaries Sanofi-Synthelabo Inc., Aventis Pharmaceuticals Inc., and Sanofi Pasteur Inc. The sanofi-aventis Group is listed in Paris (EURONEXT : SAN) and in New York (NYSE : SNY).